• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效液相色谱法测定哮喘患者支气管肺泡灌洗中布地奈德的含量

High-performance liquid chromatographic method for the determination of budesonide in bronchoalveolar lavage of asthmatic patients.

作者信息

Faouzi M A, Dine T, Luyckx M, Brunet C, Gressier B, Cazin M, Wallaert B, Cazin J C

机构信息

Laboratoire de Pharmacologie, Faculté des Sciences Pharmaceutiques et Biologiques, Lille, France.

出版信息

J Chromatogr B Biomed Appl. 1995 Feb 17;664(2):463-7. doi: 10.1016/0378-4347(94)00473-i.

DOI:10.1016/0378-4347(94)00473-i
PMID:7780604
Abstract

A simple, sensitive and selective method for the determination of budesonide in bronchoalveolar lavage (BAL) using high-performance liquid chromatography (HPLC) with UV detection was developed. BAL samples were extracted twice with methylene chloride, the extracts were centrifuged and the organic layer separated and dried under nitrogen. The samples were reconstituted in the mobile phase and 80 microliters were injected on to a Spherisorb ODS column with UV absorbance detection at 250 nm. The mobile phase was methanol-aqueous buffer (69:31, v/v). Inter-assay coefficients of variation were measured at 7.81 and 500 ng/ml with ranges of 0.89-7.31%. Average recoveries were 97% or greater. This method was successfully implemented for the analysis of BAL from asthmatics, in order to establish the amount of budesonide available to the lung and to investigate the efficacy of inhaler systems. Patients (n = 9) inhaled four puffs of 200 micrograms of budesonide and BAL was performed 10 min after the last inhalation. Only four BAL out of the nine presented detectable amounts of budesonide. The concentrations in BAL in these four patients were 13.44-84.18 ng/ml, corresponding to total amounts of 0.847-7.997 micrograms.

摘要

建立了一种使用高效液相色谱(HPLC)结合紫外检测法测定支气管肺泡灌洗(BAL)中布地奈德的简单、灵敏且选择性高的方法。BAL样本用二氯甲烷萃取两次,萃取液离心,分离有机层并在氮气下干燥。样本用流动相复溶,取80微升注入Spherisorb ODS柱,在250nm处进行紫外吸光度检测。流动相为甲醇 - 水性缓冲液(69:31,v/v)。批间变异系数在7.81和500 ng/ml时测定,范围为0.89 - 7.31%。平均回收率为97%或更高。该方法成功用于分析哮喘患者的BAL,以确定肺部可利用的布地奈德量并研究吸入器系统的疗效。患者(n = 9)吸入4喷200微克的布地奈德,在最后一次吸入后10分钟进行BAL。9份BAL样本中只有4份检测到可检测量的布地奈德。这4名患者BAL中的浓度为13.44 - 84.18 ng/ml,对应总量为0.847 - 7.997微克。

相似文献

1
High-performance liquid chromatographic method for the determination of budesonide in bronchoalveolar lavage of asthmatic patients.高效液相色谱法测定哮喘患者支气管肺泡灌洗中布地奈德的含量
J Chromatogr B Biomed Appl. 1995 Feb 17;664(2):463-7. doi: 10.1016/0378-4347(94)00473-i.
2
Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects.在健康受试者中,与通过氯氟烃定量吸入器吸入布地奈德相比,通过氢氟烷烃定量吸入器吸入环索奈德时下咽部沉积情况。
Eur J Clin Pharmacol. 2005 May;61(3):203-8. doi: 10.1007/s00228-005-0910-0. Epub 2005 Apr 12.
3
Measurement of cefuroxime in human bronchoalveolar lavage fluid by high-performance liquid chromatography after solid-phase extraction.
J Chromatogr B Biomed Sci Appl. 1997 Feb 21;689(2):438-41. doi: 10.1016/s0378-4347(96)00329-5.
4
Theophylline vs. budesonide in the treatment of mild-to-moderate bronchial asthma.茶碱与布地奈德治疗轻至中度支气管哮喘的对比
Respiration. 1994;61(5):241-8. doi: 10.1159/000196346.
5
How much nebulised budesonide reaches infants and toddlers?有多少雾化吸入的布地奈德能到达婴幼儿体内?
Arch Dis Child. 1992 Sep;67(9):1077-9. doi: 10.1136/adc.67.9.1077.
6
The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler.延迟、多次启动以及雾化器静电荷对布地奈德从雾化吸入器体外递送的影响。
Br J Clin Pharmacol. 1995 Jul;40(1):76-8. doi: 10.1111/j.1365-2125.1995.tb04538.x.
7
Granulocyte function in the airways of allergen-challenged pigs: effects of inhaled and systemic budesonide.变应原激发猪气道中的粒细胞功能:吸入和全身性布地奈德的影响
Clin Exp Allergy. 1996 Dec;26(12):1436-48.
8
Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma.中度哮喘患者中吸入布地奈德每日一次与每日两次给药的长期临床比较
Thorax. 1995 Dec;50(12):1270-3. doi: 10.1136/thx.50.12.1270.
9
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage.一种用于测定人血浆和支气管肺泡灌洗液中抗生素利奈唑胺的新型高效液相色谱 - 紫外检测法的验证
Biomed Chromatogr. 2013 Nov;27(11):1489-96. doi: 10.1002/bmc.2947. Epub 2013 Jul 1.
10
Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.使用都保装置吸入800微克布地奈德与使用带储雾罐的压力定量气雾剂吸入≥1500微克二丙酸倍氯米松在哮喘管理方面疗效相当。法国布地奈德试验组。
Adv Ther. 1996 Jan-Feb;13(1):38-50.

引用本文的文献

1
Bioavailability of budesonide delivered by the clickhaler® and turbuhaler® dry powder inhalers in healthy volunteers : a pilot study.布地奈德经点击式干粉吸入器和都保®干粉吸入器在健康志愿者中的生物利用度:一项初步研究。
Clin Drug Investig. 2002;22(2):119-24. doi: 10.2165/00044011-200222020-00006.
2
Development and validation of a rapid HPLC method for simultaneous analysis of budesonide and its novel synthesized hemiesters in colon specific formulations.用于同时分析结肠靶向制剂中布地奈德及其新合成半酯的快速高效液相色谱法的开发与验证
Res Pharm Sci. 2011 Jul;6(2):107-16.
3
Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study.
喷雾干燥技术制备布地奈德微粒用于肺部给药:设计、表征、体外评价和体内药效学研究。
AAPS PharmSciTech. 2009;10(3):993-1012. doi: 10.1208/s12249-009-9290-6. Epub 2009 Aug 1.
4
Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology.使用超临界流体沉淀技术制备布地奈德及布地奈德-聚乳酸微粒。
AAPS PharmSciTech. 2002;3(3):E18. doi: 10.1208/pt030318.